Arzeda, a protein design company, has announced the closing of a $38 million oversubscribed funding round.
This fundraising round brings in new investments from Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and the venture arm of W.L. Gore & Associates (makers of Gore-Tex), which has been in a joint development agreement with Arzeda since 2022. Previous investors also participated in the round, including the venture arm of the Continental Grain Company, Bunge Ventures, and Lewis & Clark Agrifood.
With this funding, Arzeda will expand the production capacity of its ProSweet Enzymes and ProSweet RebM to meet strong market demand of better tasting stevia and accelerate the commercialization of additional breakthrough products in its pipeline. Arzeda has partnered with several global industrial leaders to bring these products to the market including Unilever, AAK, and W.L. Gore & Associates.
Arzeda’s Intelligent Protein Design Technology is built on one of the largest proprietary datasets of high-quality protein designs linked to experimental results and leverages the latest advances in generative artificial intelligence to design and manufacture higher-performing proteins and enzymes tailored for large-scale production. Arzeda’s proteins and enzymes enable alternatives which outperform existing products across various industries, including food, personal and home care, agriculture, chemicals, materials, pharmaceuticals, and diagnostics, in a more sustainable manner.
